Elixinol Wellness Ltd (EXL) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.199x

Based on the latest financial reports, Elixinol Wellness Ltd (EXL) has a cash flow conversion efficiency ratio of -0.199x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-1.38 Million ≈ $-978.56K USD) by net assets (AU$6.96 Million ≈ $4.93 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Elixinol Wellness Ltd - Cash Flow Conversion Efficiency Trend (2002–2024)

This chart illustrates how Elixinol Wellness Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read debt load of Elixinol Wellness Ltd for a breakdown of total debt and financial obligations.

Elixinol Wellness Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Elixinol Wellness Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Scancell Hldgs Plc
LSE:SCLP
0.846x
Gujarat Lease Financing Limited
NSE:GLFL
0.049x
Aker Carbon Capture ASA
OL:ACC
-0.772x
ProAm Explorations Corp
V:PMX
0.370x
Osteopore Ltd
AU:OSX
3.011x
Ferrexpo PLC
LSE:FXPO
-0.032x
Stelrad Group PLC
LSE:SRAD
0.108x
Fonix Mobile plc
LSE:FNX
0.339x

Annual Cash Flow Conversion Efficiency for Elixinol Wellness Ltd (2002–2024)

The table below shows the annual cash flow conversion efficiency of Elixinol Wellness Ltd from 2002 to 2024. For the full company profile with market capitalisation and key ratios, see Elixinol Wellness Ltd (EXL) market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 AU$10.03 Million
≈ $7.09 Million
AU$-3.47 Million
≈ $-2.45 Million
-0.346x +18.93%
2023-12-31 AU$6.46 Million
≈ $4.57 Million
AU$-2.76 Million
≈ $-1.95 Million
-0.427x +52.05%
2022-12-31 AU$9.16 Million
≈ $6.48 Million
AU$-8.15 Million
≈ $-5.77 Million
-0.890x -20.68%
2021-12-31 AU$19.08 Million
≈ $13.50 Million
AU$-14.07 Million
≈ $-9.96 Million
-0.738x -16.25%
2020-12-31 AU$35.65 Million
≈ $25.23 Million
AU$-22.62 Million
≈ $-16.01 Million
-0.635x -38.40%
2019-12-31 AU$111.38 Million
≈ $78.81 Million
AU$-51.07 Million
≈ $-36.13 Million
-0.458x -1154.74%
2018-12-31 AU$143.74 Million
≈ $101.70 Million
AU$-5.25 Million
≈ $-3.72 Million
-0.037x -457.88%
2017-12-31 AU$99.09 Million
≈ $70.11 Million
AU$-649.00K
≈ $-459.21K
-0.007x -103.27%
2005-12-31 AU$392.73 Million
≈ $277.88 Million
AU$78.77 Million
≈ $55.74 Million
0.201x -52.91%
2004-12-31 AU$260.84 Million
≈ $184.56 Million
AU$111.09 Million
≈ $78.61 Million
0.426x +53.92%
2003-12-31 AU$175.18 Million
≈ $123.95 Million
AU$48.47 Million
≈ $34.30 Million
0.277x +43.04%
2002-12-31 AU$117.25 Million
≈ $82.96 Million
AU$22.68 Million
≈ $16.05 Million
0.193x --

About Elixinol Wellness Ltd

AU:EXL Australia Drug Manufacturers - Specialty & Generic
Market Cap
$2.05 Million
AU$2.90 Million AUD
Market Cap Rank
#29662 Global
#1757 in Australia
Share Price
AU$0.01
Change (1 day)
+0.00%
52-Week Range
AU$0.01 - AU$0.02
All Time High
AU$4.91
About

Elixinol Wellness Limited, a holding company, provides healthy products in Australia, the Americas, and internationally. The company provides human nutrition, human wellness, pet wellness, and superfood ingredients under Hemp Foods Australia, Mt Elephant, The Healthy Chef, Soul Foods, Ananda Equine, and Field Day brands. It distributed through grocery, wholesale, and e-commerce channels for white… Read more